20–22 Mar 2024
Universität der Bundeswehr München
Europe/Berlin timezone

Impact of positioning uncertainty of detectors on the dosimetry of Particle Minibeam Therapy.

22 Mar 2024, 11:40
20m
Casino (Universität der Bundeswehr München)

Casino

Universität der Bundeswehr München

Werner-Heisenberg-Weg 39 85577 Neubiberg
Oral presentation Dosimetry of Particle Minibeams Dosimetry of Particle Minibeam production and application

Speaker

Dr John Cotterill (Medical Radiation Science Group, National Physical Laboratory, Teddington TW11 0LW, United Kingdom)

Description

An experimental campaign was conducted at Institut Curie, France, to perform dosimetry with the Primary Standard Proton Calorimeter (PSPC) developed by the National Physical Laboratory (NPL), UK, in proton minibeams. The minibeams were produced using a collimator with 400µm wide slits of 5cm length and 4mm separation. Dosimetry was also performed with EBT3 radiochromic film and PTW Roos chambers.

The dose distribution was determined from EBT3 radiochromic film, and the integrated dose calculated over the sensitive area of each detector in the centre of this distribution. The dose in the same sized region was then calculated after applying a lateral offset, representing experimental positioning uncertainty of the detector. This calculation was also performed for PTW Advanced Markus and PTW Bragg Peak chambers for additional comparison.

The dose was found to increase by approximately 8% when applying a 2mm offset to the position of the calorimeter and PTW Roos chambers compared to that when aligned centrally. In comparison, the dose decreased by approximately 8% in the case of the PTW Advanced Markus chamber, and decreased by <1% for the PTW Bragg Peak chamber.

The significant difference in the dose when applying a small lateral offset highlights the difficulties in performing reference dosimetry for minibeams. The results also demonstrate there is an interplay effect between the size of the sensitive region of the detector and the specific configuration of the minibeams. A much larger sensitive region demonstrated a much-reduced effect, highlighting that encapsulating more of the beam when performing dosimetry would reduce the uncertainty on the measurement. A device such as a Dose-Area-Product calorimeter currently under development at NPL could help address this for the purpose of primary standard dosimetry of spatially fractionated radiotherapy.

Fig[1]: https://drive.google.com/file/d/1lZ9GUHlmy2FdkUQ5XYIR-Rzw8xsTUQDN/view?usp=drive_link "Dose over the detectors' sensitive area with lateral offset, relative to that with zero offset."

Primary author

Dr John Cotterill (Medical Radiation Science Group, National Physical Laboratory, Teddington TW11 0LW, United Kingdom)

Co-authors

Dr Sam Flynn (Medical Radiation Science Group, National Physical Laboratory, Teddington TW11 0LW, United Kingdom; Particle Physics Group, School of Physical and Astronomy, University of Birmingham, Edgbaston, B15 2TT, United Kingdom) Prof. Russell Thomas (Medical Radiation Science Group, National Physical Laboratory, Teddington TW11 0LW, United Kingdom; University of Surrey, Faculty of Engineering and Physical Science, Guildford GU2 7XH, United Kingdom) Dr Anna Subiel (Medical Radiation Science Group, National Physical Laboratory, Teddington TW11 0LW, United Kingdom; Department of Medical Physics and Biomedical Engineering, University College London, London WC1E 6BT, United Kingdom) Mr Nigel Lee (Medical Radiation Science Group, National Physical Laboratory, Teddington TW11 0LW, United Kingdom) Mr Michael Homer (Medical Radiation Science Group, National Physical Laboratory, Teddington TW11 0LW, United Kingdom) Dr Hugo Palmans (Medical Radiation Science Group, National Physical Laboratory, Teddington TW11 0LW, United Kingdom; Medical Physics Group, MedAustron Ion Therapy Center, A-2700 Wiener Neustadt, Austria) Dr Ludovic De Marzi (Institut Curie, Radiation Oncology Department, PSL Research University, University Paris Saclay, INSERM LITO U1288, Campus universitaire, Orsay 91898, France) Dr Yolanda Prezado (Université Paris-Saclay, CNRS UMR3347, Inserm U1021, Signalisation Radiobiologie et Cancer, 91400 Orsay, France) Dr Ana Lourenco (Medical Radiation Science Group, National Physical Laboratory, Teddington TW11 0LW, United Kingdom; Department of Medical Physics and Biomedical Engineering, University College London, London WC1E 6BT, United Kingdom)

Presentation materials

There are no materials yet.